CD95-mediated control of anti-citrullinated protein/peptides antibodies (ACPA)-producing plasma cells occurring in rheumatoid arthritis inflamed joints

Rheumatology

Volumn 46, Issue 4, 2007, Pages 612-616

  Rodríguez Bayona, Beatriz ^a   Pérez Venegas, José J ^a   Rodríguez, Carmen ^a   Brieva, José A ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

Anti citrullinated protein peptides antibodies (ACPA) IgG; CD95 mediated apoptosis; Human; Plasma cell; RA; SF

Indexed keywords

ANTIRHEUMATIC AGENT; CD19 ANTIGEN; CD27 ANTIGEN; CD38 ANTIGEN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; FAS ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; LEFLUNOMIDE; LIPOCORTIN 5; METHOTREXATE; PREDNISOLONE; SYNDECAN 1;

ADULT; AGED; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; CELL ACTIVITY; CELL FUNCTION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; MALE; MONONUCLEAR CELL; MONOTHERAPY; PLASMA CELL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SURVIVAL TIME; SYNOVIAL FLUID;

ADULT; AGED; ANTIGENS, CD95; APOPTOSIS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CELL SURVIVAL; CELLS, CULTURED; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; PLASMA CELLS; SYNOVIAL FLUID;

EID: 34047143813     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel395     Document Type: Article

References (18)

1. Magalhães R, Stiehl P, Morawietz L, Berek C, Krenn V. Morphological and molecular pathology of the B cell response in synovitis of rheumatoid arthritis. Virchows Arch 2002;441:415-27.
2. Schellekens GA, Visser H, de Jong BA et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000;43:155-63.
3. Masson-Bessiere C, Sebbag M, Durieux JJ et al. In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin Exp Immunol 2000;119:544-52.
4. Reparon-Schuijt CC, van Esch WJ, van Kooten C et al. Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis. Arthritis Rheum 2001;44:41-7.
5. van Gaalen F, Ioan-Facsinay A, Huizinga TW, Toes RE. The devil in the details: The emerging role of anticitrulline autoimmunity in rheumatoid arthritis. J Immunol 2005;175:5575-80.
6. Nagata S, Suda T. Fas and Fas ligand: Lpr and gld mutations. Immunol Today 1995;16:39-43.
7. Peng SL. Fas (CD95)-related apoptosis and rheumatoid arthritis. Rheumatology 2006;45:26-30.
8. Medina F, Segundo C, Campos-Caro A, Gonzalez-Garcia I, Brieva JA. The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression. Blood 2002;99:2154-61.
9. Medina F, Segundo C, Rodriguez C, Brieva JA. Regulatory role of CD95 ligation on human B cells induced in vivo capable of spontaneous and high-rate Ig secretion. Eur J Immunol 1997;27:700-6.
10. Shapiro-Shelef M, Calame K. Regulation of plasma cell development. Nat Rev Immunol 2005;5:230-42.
11. González-García I, Ocaña E, Jiménez-Gómez G, Campos-Caro A, Brieva JA. Immunization-induced perturbation of human blood plasma cell pool: Progressive maturation, IL-6 responsiveness and high PRDI-BF1/ Blimp1 expression are critical distinctions between antigen-specific and non-specific plasma cells. J Immunol 2006;176:4042-50.
12. Pelletier N, Casamayor-Palleja M, De Luca K et al. The endoplasmic reticulum is a key component of the plasma cell death pathway. J Immunol 2006;176:1340-7.
13. Rieux-Laucat F, Le Deist F, Hivroz C et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995;268:1347-9.
14. Davidson WF, Giese T, Fredrickson TN. Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions. J Exp Med 1998;187:1825-38.
15. Brieva JA, Roldan E, Rodriguez C, Navas G. Human tonsil, blood and bone marrow in vivo-induced B cells capable of spontaneous and high-rate immunoglobulin secretion in vitro: Differences in the requirements for factors and for adherent and bone marrow stromal cells, as well as distinctive adhesion molecule expression. Eur J Immunol 1994;24:362-6.
16. Cantwell MJ, Hua T, Zvaifler NJ, Kipps TJ. Deficient Fas ligand expression by synovial lymphocytes from patients with rheumatoid arthritis. Arthritis Rheum 1997;40:1644-52.
17. Jonsson H, Allen P, Peng SL. Inflammatory arthritis requires Foxo3a to prevent Fas ligand-induced neutrophil apoptosis. Nat Med 2005;11:666-71.
18. Lopez-Hoyos M, Marquina R, Tamayo E et al. Defects in the regulation of B cell apoptosis are required for the production of citrullinated peptide autoantibodies in mice. Arthritis Rheum 2003;48:2353-61.